简介内容:RDN2150 (Compound 25), a ZAP-70 inhibitor with an IC50 of nM, covalently binds to the C346 residue of ZAP-70, suppressing the expression of CD25 and CD69 and inhibiting the activation of CD4+ T cells, making it suitable for psoriasis research [1].